Literature DB >> 33561153

Prevalence of dyslipidemia and associated risk factors among adult residents of Mekelle City, Northern Ethiopia.

Gebremedhin Gebreegziabiher1, Tefera Belachew2, Kibrti Mehari3, Dessalegn Tamiru2.   

Abstract

INTRODUCTION: Dyslipidemia is a major risk factor for cardiovascular diseases (CVD). The prevalence of dyslipidemia is not known among Ethiopian adults. The prevalence is expected to rise due to the socio-economic development accompanied by lifestyle changes. This study was conducted to estimate the prevalence of dyslipidemia and associated risk factors among adult residents of Mekelle City.
METHODS: A community-based cross-sectional study was conducted among 321 randomly selected subjects. Data were collected on sociodemographic, anthropometric, lifestyle, and clinical characteristics of the participants using the WHO STEPS survey instrument. Data were analyzed using SPSS software version 24.0. Student's t-test and Pearson's Chi-square test were used to assessing the interrelationship between each factor and outcome variables. Bivariate and multivariable logistic regression analysis were used to identify risk factors associated with dyslipidemia. All statistical significance was considered at p ≤0.05.
RESULTS: The prevalence of dyslipidemia in this study was 66.7%. The prevalence of high low-density lipoprotein cholesterol (LDL-C), elevated triglyceride, elevated total cholesterol, and low high-density lipoprotein cholesterol (HDL-C) was 49.5%, 40.2%, 30.8%, and 16.5%, respectively. Being above 64 years (aOR: 2.196, 95% CI: 1.183-4.078) and 40-64 years old (aOR: 2.196, 95% CI: 1.183-4.078), overweight (aOR: 2.50, 95% CI: 1.314-4.756) and obesity (aOR: 15.489, 95% CI: 3.525-68.070), walking <150 minutes per week (aOR: 1.722, 95% CI: 1.004-2.953), raised fasting blood glucose (FBG) (aOR: 4.804, 95% CI: 1.925-11.988), and medium socio-economic status (aOR: 2.017, 95% CI: 1.044-3.899) were identified as significant predictors of dyslipidemia.
CONCLUSIONS: The finding of this study indicated that the prevalence of dyslipidemia is unacceptably high among adult residents of Mekelle City, which underlines an urgent need for early detection and public health interventions through the integrated involvement of public, governmental, and non-governmental organizations.

Entities:  

Mesh:

Year:  2021        PMID: 33561153      PMCID: PMC7872241          DOI: 10.1371/journal.pone.0243103

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  39 in total

1.  The Enigma of Glucose and Lipid Metabolism.

Authors:  Neha J Pagidipati; Michael Pencina; Allan D Sniderman
Journal:  JAMA Cardiol       Date:  2016-05-01       Impact factor: 14.676

2.  Serum lipid levels in an Iranian adults population: Tehran Lipid and Glucose Study.

Authors:  F Azizi; M Rahmani; A Ghanbarian; H Emami; P Salehi; P Mirmiran; N Sarbazi
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

3.  Anti-Retroviral Therapy Increases the Prevalence of Dyslipidemia in South African HIV-Infected Patients.

Authors:  Joel A Dave; Naomi S Levitt; Ian L Ross; Miguel Lacerda; Gary Maartens; Dirk Blom
Journal:  PLoS One       Date:  2016-03-17       Impact factor: 3.240

4.  Impact of the Use of Different Diagnostic Criteria in the Prevalence of Dyslipidemia in Pregnant Women.

Authors:  Alina Coutinho Rodrigues Feitosa; Luciana Tedgue Barreto; Isabela Matos da Silva; Felipe Freire da Silva; Gilson Soares Feitosa
Journal:  Arq Bras Cardiol       Date:  2017-06-01       Impact factor: 2.000

5.  Dyslipidemia prevalence, awareness, treatment, control, and risk factors in Chinese rural population: the Henan rural cohort study.

Authors:  Xiaotian Liu; Songcheng Yu; Zhenxing Mao; Yuqian Li; Haiqing Zhang; Kaili Yang; Honglei Zhang; Ruihua Liu; Xinling Qian; Linlin Li; Ronghai Bie; Chongjian Wang
Journal:  Lipids Health Dis       Date:  2018-05-22       Impact factor: 3.876

6.  The prevalence and risk factors of dyslipidemia in different diabetic progression stages among middle-aged and elderly populations in China.

Authors:  Yaru Li; Liyun Zhao; Dongmei Yu; Gangqiang Ding
Journal:  PLoS One       Date:  2018-10-16       Impact factor: 3.240

7.  The Prevalence of Dyslipidemia among Jordanians.

Authors:  Mousa Abujbara; Anwar Batieha; Yousef Khader; Hashem Jaddou; Mohammed El-Khateeb; Kamel Ajlouni
Journal:  J Lipids       Date:  2018-10-28

8.  Prevalence of Dyslipidemia in Undiagnosed Palestinian Men: A Cross-Sectional Study.

Authors:  Iyad Ali; Aya Kharma; Malak Samara; Samar Odeh; Nidal Jaradat; Abd Nasser Zaid; Mahdi Al Sayed Ahmad
Journal:  J Lipids       Date:  2019-10-13

9.  Prevalence of dyslipidemia in urban and rural India: the ICMR-INDIAB study.

Authors:  Shashank R Joshi; Ranjit Mohan Anjana; Mohan Deepa; Rajendra Pradeepa; Anil Bhansali; Vinay K Dhandania; Prashant P Joshi; Ranjit Unnikrishnan; Elangovan Nirmal; Radhakrishnan Subashini; Sri Venkata Madhu; Paturi Vishnupriya Rao; Ashok Kumar Das; Tanvir Kaur; Deepak Kumar Shukla; Viswanathan Mohan
Journal:  PLoS One       Date:  2014-05-09       Impact factor: 3.240

10.  Dyslipidemia in people living with HIV-AIDS in a tertiary hospital in South-East Nigeria.

Authors:  Ernest Ndukaife Anyabolu
Journal:  Pan Afr Med J       Date:  2017-11-06
View more
  9 in total

1.  National high prevalence, and low awareness, treatment and control of dyslipidaemia among people aged 15-69 years in Mongolia in 2019.

Authors:  Supa Pengpid; Karl Peltzer
Journal:  Sci Rep       Date:  2022-06-21       Impact factor: 4.996

2.  AKT/PACS2 Participates in Renal Vascular Hyperpermeability by Regulating Endothelial Fatty Acid Oxidation in Diabetic Mice.

Authors:  Zhihao Shu; Shuhua Chen; Hong Xiang; Ruoru Wu; Xuewen Wang; Jie Ouyang; Jing Zhang; Huiqin Liu; Alex F Chen; Hongwei Lu
Journal:  Front Pharmacol       Date:  2022-07-05       Impact factor: 5.988

3.  Prevalence of dyslipidemia and associated risk factors among adult residents of Shenmu City, China.

Authors:  Huiping Gao; Haiying Wang; Guangliang Shan; Rui Liu; Haiyuan Chen; Shengli Sun; Yonglin Liu
Journal:  PLoS One       Date:  2021-05-07       Impact factor: 3.240

4.  Prevalence, patterns and determinants of dyslipidaemia among South African adults with comorbidities.

Authors:  Charity Masilela; Oladele Vincent Adeniyi; Mongi Benjeddou
Journal:  Sci Rep       Date:  2022-01-10       Impact factor: 4.996

5.  Factors associated with dyslipidemia and its prevalence among Awash wine factory employees, Addis Ababa, Ethiopia: a cross-sectional study.

Authors:  Daniel Angassa; Samrawit Solomon; Awol Seid
Journal:  BMC Cardiovasc Disord       Date:  2022-01-30       Impact factor: 2.298

6.  Determinants of Dyslipidemia in Africa: A Systematic Review and Meta-Analysis.

Authors:  Mohammed S Obsa; Getu Ataro; Nefsu Awoke; Bedru Jemal; Tamiru Tilahun; Nugusu Ayalew; Beshada Z Woldegeorgis; Gedion A Azeze; Yusuf Haji
Journal:  Front Cardiovasc Med       Date:  2022-02-23

7.  A community based cross sectional study on the prevalence of dyslipidemias and 10 years cardiovascular risk scores in adults in Asmara, Eritrea.

Authors:  Oliver Okoth Achila; Nahom Fessahye; Samuel Tekle Mengistu; Naemi Tesfamariam Habtemikael; Wintana Yebio Werke; Femal Tesfazghi Zemichael; Haben Negash Leghese; Thomas Amanuel Weldegegish; Tsegay Habteab Tekeste; Eyob Yohannes Garoy
Journal:  Sci Rep       Date:  2022-04-02       Impact factor: 4.379

8.  Prevalence, awareness, treatment, and control of dyslipidemia and associated factors among adults in Jordan: Results of a national cross-sectional survey in 2019.

Authors:  Supa Pengpid; Karl Peltzer
Journal:  Prev Med Rep       Date:  2022-06-27

9.  Prevalence and predictors of dyslipidemia among hypertensive patients in Lumame Primary Hospital, Amhara, Ethiopia: A cross-sectional study.

Authors:  Zemene Demelash Kifle; Agumas Alemu Alehegn; Meaza Adugna; Biruk Bayleyegn
Journal:  Metabol Open       Date:  2021-07-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.